From the publishers of Nature<br />
nature.com/biopharmadealmakers | March 2016<br />
Dedicated to nurturing collaboration and partnerships in the biopharma industry<br />
No stone unturned in the search for winning<br />
immuno-oncology combination therapies<br />
Originally published as an advertising feature in the March 2016 editions ofRegister Today!<br />
APRIL 17–20, 2016<br />
SAN DIEGO CONVENTION CENTER<br />
Join leaders in renewable chemicals,<br />
advanced biofuels, biobased materials<br />
and more in San Diego for the largest<br />
industrial biotechnology conference!<br />
Visit our website to receive discounted<br />
Early Bird rates until March 17th.<br />
bio.org/worldcongress #BIOWC16From the publishers of Nature<br />
nature.com/biopharmadealmakers | March 2016<br />
Dedicated to nurturing collaboration and partnerships in the biopharma indu<a title="BioPharma Dealmakers March 2016 page 1" href="http://viewer.zmags.com/publication/d54a8b39?page=1">From the publishers of Nature </a>
<a title="BioPharma Dealmakers March 2016 page 2" href="http://viewer.zmags.com/publication/d54a8b39?page=2">Register Today! APRIL 17–20, 2016 SAN DIEGO CO</a>
<a title="BioPharma Dealmakers March 2016 page 3" href="http://viewer.zmags.com/publication/d54a8b39?page=3">From the publishers of Nature </a>
<a title="BioPharma Dealmakers March 2016 page 4" href="http://viewer.zmags.com/publication/d54a8b39?page=4">Immuno-oncology dominates big pharma’s deal agend</a>
<a title="BioPharma Dealmakers March 2016 page 5" href="http://viewer.zmags.com/publication/d54a8b39?page=5">Group, a strategy-consulting firm. Every tumor typ</a>
<a title="BioPharma Dealmakers March 2016 page 6" href="http://viewer.zmags.com/publication/d54a8b39?page=6">feature Rapid turnover Novartis CEO Joseph Jim</a>
<a title="BioPharma Dealmakers March 2016 page 7" href="http://viewer.zmags.com/publication/d54a8b39?page=7">ADVERTISEMENT FEATURE OncoSec Medical I</a>
<a title="BioPharma Dealmakers March 2016 page 8" href="http://viewer.zmags.com/publication/d54a8b39?page=8">profile Toronto-based InDanio Bioscience Inc. use</a>
<a title="BioPharma Dealmakers March 2016 page 9" href="http://viewer.zmags.com/publication/d54a8b39?page=9">ADVERTISEMENT FEATURE Synaffix BV www.</a>
<a title="BioPharma Dealmakers March 2016 page 10" href="http://viewer.zmags.com/publication/d54a8b39?page=10">profile OncoTherapy Science, Inc. (OTS) is appr</a>
<a title="BioPharma Dealmakers March 2016 page 11" href="http://viewer.zmags.com/publication/d54a8b39?page=11">ADVERTISEMENT FEATURE optimized small-molec</a>
<a title="BioPharma Dealmakers March 2016 page 12" href="http://viewer.zmags.com/publication/d54a8b39?page=12">profile Netherlands-based ISA Pharmaceuticals i</a>
<a title="BioPharma Dealmakers March 2016 page 13" href="http://viewer.zmags.com/publication/d54a8b39?page=13">ADVERTISEMENT FEATURE Andes Biotechnolo</a>
<a title="BioPharma Dealmakers March 2016 page 14" href="http://viewer.zmags.com/publication/d54a8b39?page=14">profile The immunotherapy of cancer has recentl</a>
<a title="BioPharma Dealmakers March 2016 page 15" href="http://viewer.zmags.com/publication/d54a8b39?page=15">ADVERTISEMENT FEATURE SINGLE CELL TECHNOLOGY </a>
<a title="BioPharma Dealmakers March 2016 page 16" href="http://viewer.zmags.com/publication/d54a8b39?page=16">There's no better place to connect with biotech's </a>